Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

The use of JAK vs TNF inhibitors shows no significant increase in the incidence of major adverse cardiovascular events in ...

ClearPoint advances LITT and OR expansions amid partner progress. Read here to know why we believe CLPT stock is an ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.

Many rheumatologic conditions such as rheumatoid arthritis and lupus often strike women during their reproductive years, with ...

The name Brett Favre brings up two different memories in the minds of football fans. On one hand, he was one of the best ever ...

Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $590 - $605 million -- KPL-387 Phase 2/3 clinical trial ...

"A patient came in after what was described as a 'head injury.' We realized how bad it was after seeing a plastic grocery bag ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...